Frédéric Lézot

9PUBLICATIONS
14CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursProteomics and intermolecular interactions (excl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 17, 2023
Advances in Osteosarcoma.

Isidora Panez-Toro, Javier Muñoz-García, Jorge W Vargas-Franco

|Apr 12, 2022
Inhibiting Endothelin Receptors with Macitentan Strengthens the Bone Protective Action of RANKL Inhibition and Reduces Metastatic Dissemination in Osteosarcoma.

Javier Muñoz-Garcia, Jorge William Vargas-Franco, Bénédicte Brounais-Le Royer

|Jun 02, 2021
ICG-001, an Inhibitor of the β-Catenin and cAMP Response Element-Binding Protein Dependent Gene Transcription, Decreases Proliferation but Enhances Migration of Osteosarcoma Cells.

Geoffroy Danieau, Sarah Morice, Sarah Renault

|Nov 24, 2020
Sonic Hedgehog Signature in Pediatric Primary Bone Tumors: Effects of the GLI Antagonist GANT61 on Ewing's Sarcoma Tumor Growth.

Mathilde Mullard, Marie Cadé, Sarah Morice

|Sep 16, 2020
Ribosomopathies: New Therapeutic Perspectives.

Emilien Orgebin, François Lamoureux, Bertrand Isidor

|Mar 27, 2020
Origins of Alterations to Rankl Null Mutant Mouse Dental Root Development.

Andrea Gama, Jorge William Vargas-Franco, Diana Carolina Sánchez Mesa

Pageof 2

Frequent Collaborators

6 joint publications

Dominique Heymann

3 joint publications

Franck Verrecchia

2 joint publications

Benjamin Ory

2 joint publications

Bénédicte Brounais-Le Royer